Page last updated: 2024-09-04

cryptotanshinone and Psoriasis

cryptotanshinone has been researched along with Psoriasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Debnath, B; Neamati, N; Xu, S1
Feng, B; He, S; Li, C; Liu, B; Liu, H; Lu, C; Su, Z; Tang, L; Wang, X; Xu, F; Zhao, J; Zheng, G; Zheng, X; Zhu, W; Zhu, Y1

Reviews

1 review(s) available for cryptotanshinone and Psoriasis

ArticleYear
Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.
    Journal of medicinal chemistry, 2012, Aug-09, Volume: 55, Issue:15

    Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Drug Design; High-Throughput Screening Assays; Humans; Neoplasms; Peptides; Peptidomimetics; Psoriasis; Signal Transduction; STAT3 Transcription Factor; Stem Cells; Structure-Activity Relationship

2012

Other Studies

1 other study(ies) available for cryptotanshinone and Psoriasis

ArticleYear
Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3.
    Experimental dermatology, 2018, Volume: 27, Issue:3

    Topics: Animals; Cell Line; Cell Proliferation; Disease Models, Animal; Drugs, Chinese Herbal; Epidermis; Humans; Hyperplasia; Imiquimod; Keratinocytes; Male; Mice, Inbred C57BL; Phenanthrenes; Psoriasis; STAT3 Transcription Factor

2018